Able Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Able Wealth Management's PFE Position: Q3 2026 in Review
Able Wealth Management reduced its Pfizer (PFE) stake by 1.8% in Q3 2026, selling an estimated $10.8K and leaving 21,684 shares worth $594K. The position accounts for 0.13% of the portfolio, ranked #75.
Able Wealth Management first reported a position in PFE in Q4 2023 and has held it in 12 quarters since. The position peaked at $929K in Q4 2023. 972 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Able Wealth Management held 21,684 shares of Pfizer worth $594K as of Q3 2026.
- Able Wealth Management sold 407 Pfizer shares in Q3 2026, an estimated $10.8K.
- Pfizer made up 0.13% of Able Wealth Management's portfolio in Q3 2026, its #75 holding.
- Able Wealth Management first reported a position in Pfizer in Q4 2023 and has held it in 12 quarters since.
- Able Wealth Management's Pfizer position peaked at $929K in Q4 2023.
- 972 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Able Wealth Management's 13F filing for Q3 2026, filed 13 Oct 2026.